Edition:
United States

Bioblast Pharma Ltd (ORPN.OQ)

ORPN.OQ on NASDAQ Stock Exchange Capital Market

1.23USD
7 Dec 2018
Change (% chg)

$-0.02 (-1.60%)
Prev Close
$1.25
Open
$1.20
Day's High
$1.27
Day's Low
$1.15
Volume
25,371
Avg. Vol
26,922
52-wk High
$5.99
52-wk Low
$1.03

Chart for

About

Bioblast Pharma Ltd (BioBlast) is an Israel-based development-stage biopharmaceutical company. The Company is focused on the identification, licensing, acquisition, development and commercialization of drugs for rare and ultra-rare genetic and metabolic diseases. It focuses on therapeutic platforms that offer solutions for... (more)
No analyst recommendations are available for .

Overall

Beta: --
Market Cap(Mil.): $7.39
Shares Outstanding(Mil.): 3.34
Dividend: --
Yield (%): --

Financials

  ORPN.OQ Industry Sector
P/E (TTM): -- 92.25 33.63
EPS (TTM): -3.67 -- --
ROI: -119.23 0.28 15.02
ROE: -119.23 0.94 16.60

Earnings vs. Estimates